Dirk Theile
Impact in
Papers in
- Oncology 33
- Drug Transport and Resistance Mechanisms 29
-
- Advanced biosensing and bioanalysis techniques 4
- Cancer therapeutics and mechanisms 4
- Co-authors
- Johanna Weiß (49 shared papers)Walter E. Haefeli (34 shared papers)Heike Lindenmaier (2 shared papers)Caroline Henrike Storch (1 shared paper)Nahal Ketabi‐Kiyanvash (2 shared papers)Juan Pablo Rigalli (7 shared papers)Jürgen Burhenne (12 shared papers)Gerd Mikus (3 shared papers)
- Journals
- Naunyn-Schmiedeberg s Archives of Pharmacology (7 papers)Analytical Biochemistry (5 papers)Archives of Toxicology (5 papers)Cancer Chemotherapy and Pharmacology (3 papers)Biochemical Pharmacology (3 papers)
- Partner nations
- GermanyUnited StatesCzechia
In The Last Decade
Dirk Theile
58 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 105
- Virology 93
- Oncology 469
- Pharmacology 129
- Infectious Diseases 235
- Health Information Management 48
Countries citing papers authored by Dirk Theile
This map shows the geographic impact of Dirk Theile's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dirk Theile with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dirk Theile more than expected).
Fields of papers citing papers by Dirk Theile
This network shows the impact of papers produced by Dirk Theile. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dirk Theile. The network helps show where Dirk Theile may publish in the future.
Co-authors
The 25 scholars most cited alongside Dirk Theile, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 61 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 131 | |
| 2 | 2006 | 108 | |
| 3 | 2010 | 71 | |
| 4 | 2014 | 65 | |
| 5 | 2009 | 60 | |
| 6 | 2016 | 56 | |
| 7 | 2012 | 47 | |
| 8 | 2013 | 39 | |
| 9 | 2016 | 32 | |
| 10 | 2013 | 31 | |
| 11 | 2014 | 28 | |
| 12 | 2021 | 27 | |
| 13 | 2010 | 26 | |
| 14 | 2012 | 23 | |
| 15 | 2014 | 22 | |
| 16 | 2014 | 21 | |
| 17 | 2017 | 19 | |
| 18 | 2013 | 17 | |
| 19 | 2022 | 17 | |
| 20 | 2013 | 16 |
About Dirk Theile
Dirk Theile is a scholar working on Oncology, Molecular Biology, Pharmacology, Infectious Diseases and Pediatrics, Perinatology and Child Health, having authored 61 papers that have together received 1.1k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (29 papers), Pharmacogenetics and Drug Metabolism (15 papers), Pharmacological Effects and Toxicity Studies (11 papers), HIV/AIDS drug development and treatment (10 papers), Estrogen and related hormone effects (5 papers), Multiple Myeloma Research and Treatments (4 papers), Advanced biosensing and bioanalysis techniques (4 papers) and Cancer therapeutics and mechanisms (4 papers). The work is most often cited by research in Virology (93 citations), Oncology (469 citations), Pharmacology (129 citations), Infectious Diseases (235 citations) and Health Information Management (48 citations). Dirk Theile has collaborated with scholars based in Germany, United States and Czechia. Frequent co-authors include Johanna Weiß, Walter E. Haefeli, Heike Lindenmaier, Caroline Henrike Storch, Nahal Ketabi‐Kiyanvash, Juan Pablo Rigalli, Jürgen Burhenne, Gerd Mikus, Christel Herold‐Mende and Melanie Herzog. Their work appears in journals such as Naunyn-Schmiedeberg s Archives of Pharmacology, Analytical Biochemistry, Archives of Toxicology, Cancer Chemotherapy and Pharmacology and Biochemical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.